• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Ionis Pharmaceuticals (IONS)

Common Shares
Sell: $70.00|Buy: $80.75|Change: 0.32 (0.40%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, and rare diseases. Ionis and Biogen brought Spinraza to market in 2016 as a treatment for spinal muscular atrophy, and Biogen launched ALS drug Qalsody in 2023. Ionis brought two additional drugs to market via its cardiovascular-focused subsidiary Akcea, including ATTR amyloidosis drug Tegsedi (2018) and cardiology drug Waylivra (Europe, 2019). Ionis and AstraZeneca launched polyneuropathy drug Wainua in 2024. Ionis received FDA approval in 2024 for Tryngolza for a rare high-triglyceride syndrome, marking its first independent launch.

Address

2855 Gazelle Court
Carlsbad
CA
USA
92010

Telephone

+1 760 931-9200

Website

https://www.ionis.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Ionis Pharmaceuticals Inc Third Quarter Earnings Conference Call for 20262026-10-29T11:30:00
Ionis Pharmaceuticals Inc Third Quarter Earnings Results for 20262026-10-29T00:00:00
Ionis Pharmaceuticals Inc Second Quarter Earnings Conference Call for 20262026-07-30T11:30:00
Ionis Pharmaceuticals Inc Second Quarter Earnings Results for 20262026-07-30T00:00:00
Ionis Pharmaceuticals Inc Annual General Meeting for 20262026-06-05T14:00:00
Ionis Pharmaceuticals Inc First Quarter Earnings Conference Call for 20262026-04-30T11:30:00
Ionis Pharmaceuticals Inc First Quarter Earnings Results for 20262026-04-30T00:00:00
Ionis Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 20252026-02-19T11:30:00
Ionis Pharmaceuticals Inc Fourth Quarter Earnings Results for 20252026-02-19T00:00:00
Ionis Pharmaceuticals Inc Annual Report for 20252026-02-19T00:00:00

Previous key dates

NameKey Date
Ionis Pharmaceuticals Inc Jefferies Global Healthcare Conference 20252025-11-18T08:30:00
Ionis Pharmaceuticals Inc Stifel Healthcare Conference 20252025-11-13T08:00:00
Webcast from AHA to Discuss Olezarsen CORE and CORE2 Data2025-11-08T15:00:00
Ionis Pharmaceuticals Inc Third Quarter Earnings Conference Call for 20252025-10-29T11:30:00
Ionis Pharmaceuticals Inc Third Quarter Earnings Result for 20252025-10-29T00:00:00
Ionis to host investors and analysts for Innovation Day 20252025-10-07T08:30:00
Morgan Stanley 23rd Annual Global Healthcare Conference2025-09-09T12:20:00
H.C. Wainwright 27th Annual Global Investment Conference2025-09-08T15:00:00
2025 Wells Fargo Healthcare Conference2025-09-04T10:15:00
Positive CORE and CORE2 Topline Results Webcast2025-09-02T08:30:00
Ionis Pharmaceuticals Inc Second Quarter Earnings Conference Call for 20252025-07-30T11:30:00
Ionis Pharmaceuticals Inc Second Quarter Earnings Results for 20252025-07-30T00:00:00
Ionis Pharmaceuticals Inc Annual General Meeting for 20252025-06-05T14:00:00
2025 RBC Capital Markets Global Healthcare Conference2025-05-21T08:00:00
Bank of America 2025 Health Care Conference2025-05-14T12:20:00
Ionis Pharmaceuticals Inc First Quarter Earnings Conference Call for 20252025-04-30T11:30:00
Ionis Pharmaceuticals Inc First Quarter Earnings Result for 20252025-04-30T00:00:00
24th Annual Needham Virtual Healthcare Conference2025-04-07T15:00:00
Stifel 2025 Virtual CNS Forum2025-03-19T10:00:00
UBS Virtual CNS Day 20252025-03-17T14:00:00
Barclays 27th Annual Global Healthcare Conference2025-03-12T13:00:00
Leerink Global Healthcare Conference 20252025-03-11T15:00:00
TD Cowen 45th Annual Health Care Conference2025-03-04T10:30:00
Raymond James 46th Annual Institutional Investors Conference2025-03-04T08:40:00
Ionis Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 20242025-02-19T11:30:00
Ionis Pharmaceuticals Inc Fourth Quarter Earnings Result for 20242025-02-19T00:00:00
Ionis Pharmaceuticals Inc Annual Report for 20242025-02-19T00:00:00
43rd Annual J.P. Morgan Healthcare Conference2025-01-15T10:30:00
Piper Sandler 36th Annual Healthcare Conference2024-12-04T09:00:00
Citi's 2024 Global Healthcare Conference2024-12-03T08:45:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.